CPC-410
CPC-410 is а mitochondria-targeted drug for safe and effective treatment of advanced metastatic radio-therapy-resistant, chemo-therapy-resistant and hypoxic solid tumors.
Loading menu...
|
Prostate Cancer (PCa) will affect most men if they live long enough and PCa is one of the leading causes of cancer deaths. |
Each year over 200,000 men are newly diagnosed with PCa in North America. | CPC-100 is for asympto-matic 'watchfull waiting' PCa patients who fail prostate removal & hormone therapy, with no approved drug availble to them. |
